Influenza and the work of the World Health Organization.

scientific article

Influenza and the work of the World Health Organization. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0264-410X(02)00121-4
P698PubMed publication ID12110248

P2093author name stringKitler ME
Lavanchy D
Gavinio P
P2860cites workPandemic Threat Posed by Avian Influenza A VirusesQ22299330
Initial genetic characterization of the 1918 "Spanish" influenza virusQ28305563
Characterization of a human H9N2 influenza virus isolated in Hong KongQ30233582
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatmentQ30304330
The next pandemic influenza virus?Q30416580
Emerging infections: pandemic influenzaQ30425597
Surveillance for pandemic influenzaQ30427935
Predictions for future human influenza pandemicsQ30427938
Perspectives on pandemics: a research agendaQ30427942
Respiratory viral infections in the elderlyQ33834945
Fish farming and influenza pandemicsQ34552859
Emerging viruses: defining the rules for viral trafficQ37777266
Variation of influenza A, B, and C virusesQ40326626
An outbreak of influenza aboard a commercial airlinerQ40867901
Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in AsiaQ43209344
Economic impact of influenza. The individual's perspectiveQ45396370
Influenza: viral determinants of the pathogenicity and epidemicity of an invariant disease of variable occurrenceQ72423806
P407language of work or nameEnglishQ1860
P921main subjectWorld Health OrganizationQ7817
P304page(s)S5-14
P577publication date2002-05-01
P1433published inVaccineQ7907941
P1476titleInfluenza and the work of the World Health Organization.
P478volume20 Suppl 2

Reverse relations

cites work (P2860)
Q36333306A global map of hemispheric influenza vaccine recommendations based on local patterns of viral circulation
Q35455493Challenges in antigenic characterization of circulating influenza A(H3N2) viruses during the 2011-2012 influenza season: an ongoing problem?
Q57102604Changing perceptions: of pandemic influenza and public health responses
Q33743992Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses
Q30361736Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin
Q30226736Disease mongering and the fear of pandemic influenza
Q38634886Establishment of minimal positive-control conditions to ensure brain safety during rapid development of emergency vaccines
Q30394940Evaluation of Haemagglutinin Content by RP-HPLC to Generate Pandemic Influenza Vaccine
Q33749154Evaluation of Southern Hemisphere influenza vaccine recommendations
Q33780455Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants
Q30421871Evidence-based medicine and the governance of pandemic influenza
Q30374103HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines.
Q30373729Heterosubtypic protection conferred by combined vaccination with M2e peptide and split influenza vaccine.
Q47182639History and current trends in influenza virus infections with special reference to Sri Lanka
Q31137989Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14.
Q38399586Influenza seasonality goes south in the Yucatan Peninsula: The case for a different influenza vaccine calendar in this Mexican region
Q30218943Influenza virus surveillance in Pakistan during 2008-2011.
Q41830705Influenza: environmental remodeling, population dynamics, and the need to understand networks
Q30366187Lessons from 40 years' surveillance of influenza in England and Wales.
Q40561436Methadone enhances human influenza A virus replication
Q34471943Methamphetamine reduces human influenza A virus replication
Q37079415Modulation of signaling pathways by RNA virus capsid proteins
Q47356431Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine
Q30453383Nanorobot Hardware Architecture for Medical Defense
Q60266951Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults
Q33302937Phylogenetic analysis reveals the global migration of seasonal influenza A viruses
Q35546254Prevention and Control of Influenza
Q56427001Public Health Importance and Pandemic Potentials/Threats of Influenza Viruses
Q30356733The Spanish influenza of 1918 in St. Louis, Missouri.
Q33427870The dilemma of influenza vaccine recommendations when applied to the tropics: the Brazilian case examined under alternative scenarios
Q30428703The politics of medicine and the global governance of pandemic influenza.
Q24645031Vaccination and antigenic drift in influenza
Q90699510Verification with the utility of an established rapid assessment of brain safety for newly developed vaccines
Q21146091Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses